Clinical Trial

A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects

Name: A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects — clinical trial record (NCT07414602)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The Phase I clinical study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-1894 in healthy subjects.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-10.

Status change: Not Yet Recruiting → Recruiting 2026-03-16

Trial Details

NCT Number	NCT07414602
Lead Sponsor	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions	Dermatitis
Enrollment	40 participants
Start Date	2026-03-16
Primary Completion	2026-10 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-18